Olympus Corp (OLYMY)
Olympus Corp is a Japanese healthcare equipment and supplies company whose operations are represented in the listed security as an American depositary receipt on OTC Markets. Through its subsidiaries, the company develops and sells medical equipment across Japan, the Americas, the Middle East, Asia, and Oceania. Its business is organized into Endoscopic Solutions, Therapeutic Solutions, and Other segments. Olympus’s product range includes gastrointestinal endoscopy systems, GI endotherapy tools, endoscopic ecosystem software and AI-enabled detection and diagnosis products, reprocessing equipment, and related medical services. The company also supplies respiratory, urology, surgical, gastroenterology, and gynecology products. Founded in 1919 and headquartered in Hachioji, Japan, Olympus was previously known as Olympus Optical Co., Ltd. before adopting its current name in 2003.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-OLYM.Y
|
$14.78
|
37.2% Upside
|
Undervalued
|
—
|
—
|
—
|
Good
|
—
|
—
|
—
|
0.0%
|
August 7, 2026
|
27.6x
|
2.3x
|
1.9x
|
11.459 B
|
11.061 B
|
11.3%
|
100.0%
|
7.7
|
33.1%
|
66.0%
|
